Australian Trade Distributors Stock News

GQG Partners (ASX:GQG) is back in focus after Charles Falck officially stepped into the chief financial officer role on 1 January 2026, following the retirement of long serving CFO Melodie Zakaluk. See our latest analysis for GQG Partners. The leadership change comes as the share price has shown positive momentum in recent months, with a 12.15% 90 day share price return but a 1 year total shareholder return decline of 2.25%, suggesting shorter term optimism alongside a more mixed longer term...

In late December 2025 and early January 2026, Mesoblast reshaped its governance and balance sheet, appointing Philip Facchina as non-executive Chair, Lyn Cobley as Audit and Risk Committee Chair, refinancing debt with a new up to US$125 million facility from director and shareholder Dr Gregory George, and filing US$250 million and US$9.48 million shelf registrations. These moves collectively signal Mesoblast’s progression from development-stage biotech toward a revenue-focused commercial...

BlueScope Steel: recent share performance in focus Recent trading in BlueScope Steel (ASX:BSL) has drawn attention after a strong run over the past 3 months, leaving investors weighing how the current A$29.87 share price lines up with fundamentals. See our latest analysis for BlueScope Steel. That recent 24.1% 7 day share price return and 37.97% 90 day share price return sit alongside a 58.6% 1 year total shareholder return. Together, these figures suggest strong momentum and a shift in how...

In early January 2026, South32 drew investor attention as copper prices reached record highs on supply disruption headlines, lifting sentiment across global miners ahead of the company’s late-January quarterly update and February half-year results. This combination of tighter copper supply and upcoming results has sharpened focus on how South32’s portfolio exposure to copper could influence its medium-term earnings profile. We’ll now examine how record copper prices amid supply disruption...

CSL has recently faced increased scrutiny after cutting its fiscal 2026 revenue growth outlook, pausing the planned Seqirus spin-off in response to weaker U.S. influenza vaccination demand, and committing A$1.50 billion over five years to expand its U.S. plasma-derived therapies manufacturing capacity. These moves highlight how CSL is recalibrating between a less certain vaccines backdrop and long-term investment in plasma therapies, sharpening questions about the balance between near-term...

In a recent company-backed video, investment commentator Tylah Tully reviewed Hot Chili’s progress toward definitive feasibility and near-term production at its Costa Fuego copper-gold project in Chile. The collaboration-focused presentation underscored Costa Fuego’s positioning as a globally significant copper-gold asset with a unique development advantage, highlighting key milestones on the path to production readiness. We’ll examine how this push toward definitive feasibility at Costa...

In 2025–2026, Telix Pharmaceuticals became the focus of multiple securities class action lawsuits after disclosures of an SEC subpoena and an FDA Complete Response Letter concerning its prostate cancer diagnostics and therapeutics. The allegations center on whether Telix accurately described the progress of its pipeline and the robustness of its third-party manufacturing network, raising wider questions about disclosure practices in complex biotech supply chains. We’ll now examine how...

Regis Resources (ASX:RRL) has drawn fresh attention after reporting second quarter fiscal 2026 gold production of 96,600 ounces. This comes alongside a broader gold sector rally supported by safe-haven demand and interest rate expectations. See our latest analysis for Regis Resources. The latest production update and sector tailwinds have come alongside a 27.1% 3 month share price return and a very large 1 year total shareholder return. This suggests momentum in investor expectations around...

Lynas Rare Earths recently drew renewed investor attention as markets reacted to rare-earth price signals from China and continued to focus on previously flagged operational risks at its Kalgoorlie processing facility, which could affect output at its Malaysian plant. As one of the few major rare earth producers outside China, Lynas sits at the center of efforts to secure critical mineral supply chains for electric vehicles, electronics, green energy and defense applications. We’ll now...

Wondering if FireFly Metals at A$2.03 is starting to look priced for perfection, or if the market is still underestimating it? This article walks through the key numbers so you can judge the value story for yourself. The share price has seen a 123.1% return over the last year, alongside a 9.7% gain over the past 30 days and a 2.9% decline in the last week. This hints at both interest in the stock and some short term volatility in how risk is being priced. Recent attention around FireFly...

Why Julian Sutton’s promotion matters for 4DMedical shareholders The recent 18% jump in 4DMedical (ASX:4DX) followed the appointment of long-time board member and early investor Julian Sutton as Chief Financial Officer and Executive Director on January 2, 2026. This move comes as the company shifts focus toward commercial growth, with its CT:VQ lung imaging software already FDA cleared, deployed at leading U.S. academic medical centres, and supported by a global distribution agreement with...

Calix (ASX:CXL) has drawn fresh attention after securing a three year supply contract with a major US agricultural company. The contract is expected to contribute up to A$10 million in revenue each year. See our latest analysis for Calix. The contract news arrived after a sharp move in the share price, with a 30 day share price return of 122.61% and a 90 day share price return of 224.05%. However, the 3 year total shareholder return of a 72.94% decline shows that longer term holders have had...

James Hardie Industries (ASX:JHX) has drawn fresh attention after a multi month rally that brought the stock close to its 52 week highs, as investors focus on margin discipline and resilient North American construction demand. See our latest analysis for James Hardie Industries. At A$31.35, the stock has a 1 month share price return of 5.48%, even though the 90 day share price return is a 5.69% decline and the 1 year total shareholder return is a 37.43% loss. Recent momentum is improving off...

ANZ Group Holdings has recently drawn fresh investor attention as a major Australia–New Zealand bank, with its long history of dividend payments, strong capital position and ongoing digital transformation underpinning confidence in the group’s ability to generate income for shareholders. Recent commentary highlights that investors increasingly view ANZ as a way to diversify beyond US markets while gaining exposure to Australia–New Zealand banking, underpinned by stable asset quality,...

In 2025, DroneShield secured a record A$61.6 million contract with a European military customer, eclipsing its full-year 2024 revenue and reported a very large year-on-year revenue increase in the second quarter, while also holding A$176.3 million in committed purchase orders for 2025 delivery. Following substantial insider share sales in November 2025, the company moved to tighten governance with mandatory minimum insider shareholdings and revamped trading and disclosure policies,...

QBE Insurance Group recently completed a $400 million catastrophe bond through its Bridge Street Re Ltd. program, securing three years of collateralized reinsurance protection focused on earthquake risk in Australasia and the US. This move broadens QBE’s access to insurance-linked securities and reinforces its capital management toolkit at a time of slowing premium growth. We’ll now explore how QBE’s expanded catastrophe bond protection shapes its investment narrative, particularly its...

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...

Fortescue (ASX:FMG) is back in focus after its push into copper, rare earths and lithium, alongside an outlook for iron ore prices that supports profitability and highlights its low debt, dividend yield and recent share performance. See our latest analysis for Fortescue. Recent moves in copper, rare earths and lithium sit alongside firm iron ore pricing at A$22.84 per share today, with a 90 day share price return of 18.96% and a 1 year total shareholder return of 40.56% suggesting momentum...

Northern Star Resources (ASX:NST) is under pressure after equipment failures and outages at Kalgoorlie, Jundee and Pogo reduced December quarter gold sales and prompted a cut of roughly 100,000 ounces to FY26 production guidance. See our latest analysis for Northern Star Resources. The production guidance cut has come after a sharp one day share price reaction and short term weakness, with a 7 day share price return of 4.3% decline and 30 day share price return of 4.48% decline. However, the...

The Australian market has been experiencing fluctuations, with optimism from the U.S. influencing early gains, although these have often reversed by the close of trading. Amidst this backdrop, investors seeking opportunities beyond well-known stocks might consider penny stocks—smaller or newer companies that can still offer significant potential. While the term "penny stock" may seem outdated, it remains relevant for those looking to uncover hidden value in companies with strong financial...

Everlast Minerals Ltd ( ASX:EV8 ) insiders who bought shares over the past year were rewarded handsomely last week. The...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Insiders who bought AU$254.5k worth of Chilwa Minerals Limited's ( ASX:CHW ) stock at an average buy price of AU$0.87...

Insiders who bought Ballymore Resources Limited ( ASX:BMR ) in the last 12 months may probably not pay attention to the...